Literatur

Agathokleous M, Chaveeva P, Poon LC, Kosinski P, Nicolaides KH: Meta-analysis of second-trimester markers for trisomy 21. Ultrasound Obstet Gynecol 2013. Mar;41(3):247-61. doi: 10.1002/uog.12364

Ahman A, Axelsson O, Maras G, Rubertsson C, Sarkadi A, Lindgren P: Ultrasonographic fetal soft markers in a low-risk population: prevalence, association with trisomies and invasive tests. Acta Obstet Gynecol Scand 2014. Apr;93(4):367-73. doi: 10.1111/aogs.12334

Brown DL, Roberts DJ, Miller WA. Left ventricular echogenic focus in the fetal heart: pathologic correlation. J Ultrasound Med 1994. Aug;13(8):613-6

Grati FR, Malvestiti F, Ferreira JC, Bajaj K, Gaetani E, Agrati C, Grimi B, Dulcetti F Ruggeri AM, De Toffol S, Maggi F, Wapner R, Gross S, Simoni G: Fetoplacental mosaicism: potential implications for false-positive and false-negative noninvasive prenatal screening results. Genet Med 2014. Aug;16(8):620-4. doi: 10.1038/gim.2014.3

Heling KS, Chaoui R, Flöter M: False-Negative NIPT Result for Trisomy 21. Ultraschall Med 2018. Feb;39(1):92. doi: 10.1055/s-0043-120758

Kozlowski P, Burkhardt T, Gembruch U, Gonser M, Kähler C, Kagan KO, von Kaisenberg C, Klaritsch P, Merz E, Steiner H, Tercanli S, Vetter K, Schramm T: DEGUM, ÖGUM, SGUM and FMF Germany Recommendations for the Implementation of First-Trimester Screening, Detailed Ultrasound, Cell-Free DNA Screening and Diagnostic Procedures. Ultraschall Med 2018. Jul 12. doi: 10.1055/a-0631-8898

Lau TK, Evans MI: Second-trimester sonographic soft markers: what can we learn from the experience of first-trimester nuchal translucency screening? Ultrasound Obstet Gynecol 2008 Aug;32(2):123-5. doi: 10.1002/uog.6134

Nicolaides KH: Screening for chromosomal defects. Ultrasound Obstet Gynecol 2003. Apr;21(4):313-21

Rolnik DL, Wright D, Poon LC, O'Gorman N, Syngelaki A, de Paco Matallana C, Akolekar R, Cicero S, Janga D, Singh M, Molina FS, Persico N, Jani JC, Plasencia W, Papaioannou G, Tenenbaum-Gavish K, Meiri H, Gizurarson S, Maclagan K, Nicolaides KH: Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia. N Engl J Med 2017. Aug 17;377(7):613-622. doi: 10.1056/NEJMoa1704559

Santorum M, Wright D, Syngelaki A, Karagioti N, Nicolaides KH: Accuracy of first-trimester combined test in screening for trisomies 21, 18 and 13. Ultrasound Obstet Gynecol 2017. Jun;49(6):714-720. doi: 10.1002/uog.17283

Syngelaki A, Chelemen T, Dagklis T, Allan L, Nicolaides KH: Challenges in the diagnosis of fetal non-chromosomal abnormalities at 11-13 weeks. Prenat Diagn 2011. Jan;31(1):90-102. doi: 10.1002/pd.2642

Viaux-Savelon S, Dommergues M, Rosenblum O, Bodeau N, Aidane E, Philippon O, Mazet P, Vibert-Guigue C, Vauthier-Brouzes D, Feldman R, Cohen D: Prenatal ultrasound screening: false positive soft markers may alter maternal representations and mother-infant interaction. PLoS One 2012. 7(1):e30935. doi: 10.1371/journal.pone.0030935

Wulff CB, Gerds TA, Rode L, Ekelund CK, Petersen OB, Tabor A: Danish Fetal Medicine Study Group. Risk of fetal loss associated with invasive testing following combined first-trimester screening for Down syndrome: a national cohort of 147,987 singleton pregnancies. Ultrasound Obstet Gynecol 2016. Jan;47(1):38-44. doi: 10.1002/uog.15820

« Zurück zum Artikel